The upgrade follows recent developments at Sentynl Therapeutics, a subsidiary of Zydus Lifesciences, which secured U.S. FDA approval for its Menkes disease drug candidate, Copper Histidinate, under ...

HANGZHOU CITY, ZHEJIANG, CHINA, January 19, 2026 /EINPresswire.com/ -- With the development of the pharmaceutical and ...

The Centers for Medicare & Medicaid Services just announced the next 15 brand-name medicines selected for Medicare’s drug price negotiation program, which mandates price reductions of at least 25%.

VRC Medical Services, a specialty pharmaceutical distribution company supporting clinical research, announced recent ...

The drug price erosion among patent-protected drugs in South Korea may be moderate compared to other major Asia-Pacific (APAC ...

October, the company announced that it is withdrawing the financial targets communicated on 1 June 2022. The targets are currently under revision ...

The pharmaceutical industry operates under an uncompromising mandate: zero defects. Every tablet, capsule, vial, or syringe ...

According to multiple recent market analyses, the global API market is experiencing steady growth. One comprehensive forecast ...

Nine-Point-Seven Percent CAGR Reflects Fundamental Industry Shift Toward Advanced LC-MS/MS and High-Resolution Platforms Across R&D, Manufacturing, and Outsourced Bioanalytical TestingDelray Beach, FL ...

HANGZHOU CITY, ZHEJIANG PROVINCE, CHINA, January 20, 2026 /EINPresswire.com/ -- The global fine chemicals industry is ...

Lupin announced a strategic collaboration with TB Alliance, to advance the clinical development and commercialization of Telacebec for the treatment of mycobacterial diseases, such as tuberculosis (TB ...